Bradner; James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bradner; James.The latest application filed is for "tunable endogenous protein degradation".

Company Profile

31.28.38

Bradner; James - Weston MA
Bradner; James - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tunable Endogenous Protein Degradation App 20220135967 - Buckley; Dennis ; et al.	2022-05-05
Regulating chimeric antigen receptors Grant 11,311,609 - Bradner , et al. April 26, 2	2022-04-26
Tunable endogenous protein degradation Grant 11,293,023 - Buckley , et al. April 5, 2	2022-04-05
Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use Grant 11,285,218 - Buckley , et al. March 29, 2	2022-03-29
Calmodulin Inhibitors, Chk2 Inhibitors And Rsk Inhibitors For The Treatment Of Ribosomal Disorders And Ribosomapathies App 20220008420 - BRADNER; James ; et al.	2022-01-13
Targeted Protein Degradation To Attenuate Adoptive T-cell Therapy Associated Adverse Inflammatory Responses App 20210301286 - Bradner; James ; et al.	2021-09-30
Methods to induce targeted protein degradation through bifunctional molecules Grant 11,059,801 - Bradner , et al. July 13, 2	2021-07-13
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses Grant 11,046,954 - Bradner , et al. June 29, 2	2021-06-29
Compounds And Methods For Treating Cancer App 20210147359 - Bradner; James ; et al.	2021-05-20
Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies Grant 10,980,808 - Bradner , et al. April 20, 2	2021-04-20
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use App 20210061811 - BRADNER; James ; et al.	2021-03-04
Compounds and methods for treating cancer Grant 10,934,256 - Bradner , et al. March 2, 2	2021-03-02
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use Grant 10,925,868 - Gray , et al. February 23, 2	2021-02-23
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use Grant 10,899,768 - Bradner , et al. January 26, 2	2021-01-26
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20210015929 - Bradner; James ; et al.	2021-01-21
Methods to induce targeted protein degradation through bifunctional molecules Grant 10,849,980 - Bradner , et al. December 1, 2	2020-12-01
Bromodomain inhibitor as adjuvant in cancer immunotherapy Grant 10,813,939 - Sotomayor , et al. October 27, 2	2020-10-27
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20200317635 - Bradner; James ; et al.	2020-10-08
Bifunctional Molecules For Her3 Degradation And Methods Of Use App 20200216454 - GRAY; Nathanael S. ; et al.	2020-07-09
Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use Grant 10,702,504 - Bradner , et al.	2020-07-07
Methods to induce targeted protein degradation through bifunctional molecules Grant 10,669,253 - Bradner , et al.	2020-06-02
Chromobox Protein Inhibitors And Uses Thereof App 20200024267 - Bradner; James ; et al.	2020-01-23
Compounds And Methods For Treating Cancer App 20200010418 - BRADNER; James ; et al.	2020-01-09
Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use Grant 10,525,139 - Bradner , et al. J	2020-01-07
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190374528 - GRAY; Nathanael S. ; et al.	2019-12-12
Tunable Endogenous Protein Degradation With Heterobifunctional Compounds App 20190374657 - Buckley; Dennis ; et al.	2019-12-12
Regulating Chimeric Antigen Receptors App 20190365875 - Bradner; James ; et al.	2019-12-05
Compounds and methods for treating cancer Grant 10,464,897 - Bradner , et al. No	2019-11-05
Methods to induce targeted protein degradation through bifunctional molecules Grant 10,464,925 - Bradner , et al. No	2019-11-05
Calmodulin Inhibitors, Chk2 Inhibitors And Rsk Inhibitors For The Treatment Of Ribosomal Disorders And Ribosomapathies App 20190314374 - BRADNER; James ; et al.	2019-10-17
Degradation Of Protein Kinases By Conjugation Of Protein Kinase Inhibitors With E3 Ligase Ligand And Methods Of Use App 20190263823 - BRADNER; James ; et al.	2019-08-29
Degradation Of Bromodomain-containing Protein 9 (brd9) By Conjugation Of Brd9 Inhibitors With E3 Ligase Ligand And Methods Of Us App 20190247509 - BUCKLEY; Dennis ; et al.	2019-08-15
Degradation Of Tripartite Motif-containing Protein 24 (trim24) By Conjugation Of Trim24 Inhibitors With E3 Ligase Ligand And Met App 20190209535 - BRADNER; James ; et al.	2019-07-11
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20190151457 - Bradner; James ; et al.	2019-05-23
Methods Of Downregulating Translocated Oncogene Expression Using Bromodomain Inhibitors App 20190134141 - Young; Richard A. ; et al.	2019-05-09
Targeted protein degradation using a mutant E3 ubiquitin ligase Grant 10,239,888 - Bradner , et al.	2019-03-26
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20190071415 - Bradner; James ; et al.	2019-03-07
Bifunctional Compounds For Her3 Degradation And Methods Of Use App 20190016703 - GRAY; Nathanael S. ; et al.	2019-01-17
Targeted Protein Degradation Using A Mutant E3 Ubiquitin Ligase App 20180327419 - Bradner; James ; et al.	2018-11-15
Methods to induce targeted protein degradation through bifunctional molecules Grant 10,125,114 - Bradner , et al. November 13, 2	2018-11-13
Folate-conjugated Molecules For Delivery Of Toxic Small Molecule Inhibitors To Cancer Cells And Methods Of Use App 20180280522 - Bradner; James ; et al.	2018-10-04
Method for identifying bromodomain inhibitors Grant 10,071,129 - Young , et al. September 11, 2	2018-09-11
Tunable Endogenous Protein Degradation App 20180179522 - Buckley; Dennis ; et al.	2018-06-28
Targeted Protein Degradation To Attenuate Adoptive T-cell Therapy Associated Adverse Inflammatory Responses App 20180169109 - Bradner; James ; et al.	2018-06-21
Compounds And Methods For Treating Cancer App 20180148410 - BRADNER; James ; et al.	2018-05-31
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20180134684 - Bradner; James ; et al.	2018-05-17
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20180085465 - Bradner; James ; et al.	2018-03-29
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20180009779 - Bradner; James ; et al.	2018-01-11
Bromodomain Inhibitor As Adjuvant In Cancer Immunotherapy App 20170360801 - Sotomayor; Eduardo M. ; et al.	2017-12-21
Methods to induce targeted protein degradation through bifunctional molecules Grant 9,821,068 - Bradner , et al. November 21, 2	2017-11-21
Methods to induce targeted protein degradation through bifunctional molecules Grant 9,770,512 - Bradner , et al. September 26, 2	2017-09-26
Methods to induce targeted protein degradation through bifunctional molecules Grant 9,750,816 - Bradner , et al. September 5, 2	2017-09-05
Methods to induce targeted protein degradation through bifunctional molecules Grant 9,694,084 - Bradner , et al. July 4, 2	2017-07-04
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20160243247 - Bradner; James ; et al.	2016-08-25
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20160235731 - Bradner; James ; et al.	2016-08-18
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20160235730 - Bradner; James ; et al.	2016-08-18
Methods To Induce Targeted Protein Degradation Through Bifunctional Molecules App 20160176916 - Bradner; James ; et al.	2016-06-23
Stabilized MAML peptides and uses thereof Grant 9,074,009 - Bradner , et al. July 7, 2	2015-07-07
Methods Of Downregulating Translocated Oncogene Expression Using Bromodomain Inhibitors App 20140371157 - Young; Richard A. ; et al.	2014-12-18
Treatment of cancers characterized by chromosomal rearrangement of the NUT gene Grant 8,623,853 - French , et al. January 7, 2	2014-01-07
Treatment of Cancers Characterized by Chromosomal Rearrangement of the NUT Gene App 20110213012 - French; Christopher ; et al.	2011-09-01
Stabilized Maml Peptides And Uses Thereof App 20100081611 - Bradner; James ; et al.	2010-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.